DaVita HealthCare Partners (DVA) Trading Up 13.6% on Analyst Upgrade

DaVita HealthCare Partners Inc. (NYSE:DVA)’s share price was up 13.6% during trading on Thursday after SunTrust Banks raised their price target on the stock to $70.00. SunTrust Banks currently has a hold rating on the stock. DaVita HealthCare Partners traded as high as $69.65 and last traded at $69.20. Approximately 9,753,800 shares changed hands during trading, an increase of 495% from the average daily volume of 1,639,776 shares. The stock had previously closed at $60.93.

Several other research firms have also commented on DVA. Robert W. Baird reissued a “hold” rating and set a $63.00 price target on shares of DaVita HealthCare Partners in a research report on Friday, November 10th. Zacks Investment Research lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, October 11th. Raymond James Financial raised DaVita HealthCare Partners from an “outperform” rating to a “strong-buy” rating in a research report on Thursday. KeyCorp reaffirmed a “hold” rating on shares of DaVita HealthCare Partners in a research report on Tuesday, October 10th. Finally, Bank of America cut their target price on DaVita HealthCare Partners from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 8th. Four research analysts have rated the stock with a sell rating, six have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. DaVita HealthCare Partners presently has an average rating of “Hold” and a consensus price target of $65.17.

Hedge funds and other institutional investors have recently modified their holdings of the company. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of DaVita HealthCare Partners in the 3rd quarter valued at approximately $154,000. Pzena Investment Management LLC increased its holdings in shares of DaVita HealthCare Partners by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after acquiring an additional 71 shares during the last quarter. Eqis Capital Management Inc. increased its holdings in shares of DaVita HealthCare Partners by 62.5% in the 3rd quarter. Eqis Capital Management Inc. now owns 7,473 shares of the company’s stock valued at $444,000 after acquiring an additional 2,873 shares during the last quarter. Jensen Investment Management Inc. increased its holdings in shares of DaVita HealthCare Partners by 24.2% in the 2nd quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock valued at $631,000 after acquiring an additional 1,900 shares during the last quarter. Finally, Accident Compensation Corp grew its stake in DaVita HealthCare Partners by 147.5% during the 2nd quarter. Accident Compensation Corp now owns 15,100 shares of the company’s stock worth $978,000 after buying an additional 9,000 shares during the last quarter. Institutional investors and hedge funds own 85.32% of the company’s stock.

The firm has a market capitalization of $11,529.89, a P/E ratio of 17.41, a P/E/G ratio of 12.28 and a beta of 0.97. The company has a quick ratio of 1.35, a current ratio of 1.40 and a debt-to-equity ratio of 1.79.

DaVita HealthCare Partners (NYSE:DVA) last issued its quarterly earnings data on Tuesday, November 7th. The company reported $0.81 EPS for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.13). The company had revenue of $3.92 billion for the quarter, compared to the consensus estimate of $3.91 billion. DaVita HealthCare Partners had a return on equity of 13.31% and a net margin of 3.40%. DaVita HealthCare Partners’s quarterly revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.95 earnings per share. equities analysts predict that DaVita HealthCare Partners Inc. will post 3.42 earnings per share for the current fiscal year.

DaVita HealthCare Partners declared that its Board of Directors has approved a share buyback program on Tuesday, October 10th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/12/07/davita-healthcare-partners-dva-trading-up-13-6-on-analyst-upgrade.html.

DaVita HealthCare Partners Company Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

What are top analysts saying about DaVita HealthCare Partners Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for DaVita HealthCare Partners Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit